ADGM — Adagio Medical Holdings Share News
0.000.00%
Last trade - 00:00Brief: Adagio Medical Announces Appointment Of Todd Usen As Chief Executive Officer And Director
Brief: Adagio Medical Provides Business Updates
Brief: Arya Sciences Acquisition Corp IV Approved One-Month Extension Of Time Period During Which It May Consummate Initial Business Combination
Brief: Adagio Medical To List On Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV
Brief: ARYA Sciences Acquisition Corp IV- Approved Extension Of Time Period To Consummate An Initial Business Combination To Sept 2, 2023
Brief: Arya Sciences Acquisition Says Financial Statements For Affected Period, In Quarterly Reports, Should No Longer Be Relied Upon
Factbox: Most short-lived SPAC deals of 2022
U.S. STOCKS ON THE MOVE-Change Healthcare, Skillz, Nikola, Moderna
ARYA Sciences SPAC dips after ending deal with Amicus
Brief: Arya Sciences Acquisition Corp Iv And Amicus Therapeutics, Inc. Mutually Agree To Terminate Business Combination Agreement With Respect To The Acquisition Of Amicus’ Gene Therapy Business Due To Market Conditions
Brief: Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation Of A Next-Generation Genetic Medicine Company